taxpayers watch when we've granted exclusivity to these companies, and then they watch as the prices go up, and there's not a darned thing for taxpayers to do about it. This is just fundamentally wrong.
Elizabeth Warren
The Public Record
Elizabeth Ann Warren is an American attorney, academic, and politician serving as the senior United States senator from Massachusetts since 2013. A member of the Democratic Party, she has been a prominent advocate for consumer protection, economic equality, and corporate regulation. Warren gained national recognition for her work in establishing the Consumer Financial Protection Bureau and has focused on issues such as student debt relief and healthcare reform during her tenure in the Senate.
So you would be in favor of drug importation from any place that's not doing what you call price control?
But drug competition from Canada, price negotiation, are market solutions. They're not government mandates.
I looked it up, and the organizations who are testifying here today spent a combined total of $30 million lobbying Congress last year.
Your industry isn't based on competitive markets. It's based on totally artificial taxpayer granted monopolies.
If the restrictions that prevent purchasers from importing the exact same drugs at lower prices from places like Canada were removed, we'd see some real competition, and we'd see some lower prices.
The consumer should decide when to release that credit record information to others.
Another market solution is negotiation. If the Federal Government were allowed to negotiate more competitive drug prices for Medicare beneficiaries, then prices would come down.
every time President Trump has the choice between standing up for American families or standing up for wealthy banks and giant corporations, he chooses the rich guys. Time and again, he has promised that he would ``never be beholden to the…